Advertisement

Chemotaxis of Phagocytes

  • H. U. Keller
  • J. F. Borel
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 15)

Abstract

Chemotaxis has been defined as a reaction by which the direction of locomotion is determined by chemical substances in the environment (1). Chemotactic attraction of leucocytes has first been described by Leber in 1888 and his findings were immediately integrated into Metchnikoff’s contemporary concept of inflammation. It was postulated that chemotaxis directs mobile phagocytes to the site of injury and thereby promotes efficient phagocytosis and histiolysis (2). For a long time the experimental support for this hypothesis remained rather poor (3). More recent data, however, which have been obtained with a new and more efficient in vitro technique developed by Boyden (4) show a fairly good correlation between in vitro chemotaxis and leucocyte accumulation in vivo.

Keywords

Human Serum Albumin Chemotactic Factor Chemotactic Activity Normal Rabbit Serum Negative Gradient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mc Cutcheon, M.: Physiol. Rev. 26: 319, 1946.PubMedGoogle Scholar
  2. 2.
    Leber, Th.: Fortschr. Med. 6: 460, 1888.Google Scholar
  3. 3.
    Harris, H.: Bact. Rev. 34: 529, 1954.Google Scholar
  4. 4.
    Boyden, S.V.: J. exp. Med. 115: 453, 1962.PubMedCrossRefGoogle Scholar
  5. 5.
    Keller, H.U. and E. Sorkin: Immunology 10: 409, 1966.Google Scholar
  6. 6.
    Keller, H.U. and E. Sorkin: Int. Arch. Allergy 31: 575, 1967.PubMedCrossRefGoogle Scholar
  7. 7.
    Buckley, I.K.: Exp. molec. Path. 2: 402, 1963.CrossRefGoogle Scholar
  8. 8.
    Wilkinson, P.C., J.F. Borel, V. Stecher-Levin and E. Sorkin: Nature 222: 244, 1969.PubMedCrossRefGoogle Scholar
  9. 9.
    Keller, H.U. and E. Sorkin: Experientia 24: 641, 1968.PubMedCrossRefGoogle Scholar
  10. 10.
    Ward, P.A.: Arth. Rheumat. 13: 181, 1970.CrossRefGoogle Scholar
  11. 11.
    Keller, H.U.: Immunology 10: 225, 1966.PubMedGoogle Scholar
  12. 12.
    Keller, H.U. and E. Sorkin: Int. Arch. Allergy 35: 194, 1969.PubMedCrossRefGoogle Scholar
  13. 13.
    Bryant, R.E., R.M. Desprez, M.H. Vanway and D.E. Rogers: J. exp. Med. 124: 483, 1966.PubMedCrossRefGoogle Scholar
  14. 14.
    Nachmias, V.T.: Exp. Cell Res. 51: 347, 1968.PubMedCrossRefGoogle Scholar
  15. 15.
    Cohn, Z.A. and S.I. Morse: J. exp. Med. 111: 667, 1960.PubMedCrossRefGoogle Scholar
  16. 16.
    Phelps, P.: Arthr. Rheumat. 13: 1, 1970.CrossRefGoogle Scholar
  17. 17.
    Borel, J.F., H.U. Keller and E. Sorkin: Int. Arch. Allergy 35: 194, 1969.PubMedCrossRefGoogle Scholar
  18. 18.
    Borel, J.F.: Int. Arch. Allergy 39: 247, 1970.PubMedCrossRefGoogle Scholar
  19. 19.
    Spector, W.G. and D.A. Willoughby: Bact. Rev. 27: 117, 1963.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1971

Authors and Affiliations

  • H. U. Keller
    • 1
  • J. F. Borel
    • 1
  1. 1.Schweizerisches ForschungsinstitutDavos-PlatzSwitzerland

Personalised recommendations